veloxpharma.com - Crunchbase Company Profile & Funding

Q: Where is veloxpharma.com's headquarters?

veloxpharma.com is located in Jintan, Jiangsu, China.

Q: Who invested in veloxpharma.com?

veloxpharma.com has 3 investors including Changzhou Properties And Longcheng Yingcai Chuangtou.

Q: When was the last funding round for veloxpharma.com?

veloxpharma.com closed its last funding round on obfuscated from a Series A round.

Q: How much funding has veloxpharma.com raised to date?

veloxpharma.com has raised obfuscated.

Overview

veloxpharma.com

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About veloxpharma.com

CB Rank

568716

veloxpharma.com engages in the research and development of biotechnology and drugs.

Founded

obfuscation

Private

Series A

Jintan, Jiangsu, China

1-10

www.veloxpharma.com/

Biotechnology

Medical

Pharmaceutical

Funding Rounds

Series A

OBF

obfuscation

Angel

OBF

obfuscation

Details

Legal Name

Velox Pharmaceuticals, Inc.

Also Known As

费洛斯药业, 常州费洛斯药业科技有限公司, Feiluosi Yaoye

Operating Status

Active

Company Type

For Profit

Phone Number

0519-81230556

Contact Email

hemeigui@veloxpharma.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

CAB Combination Antibody Library Technology

A platform for rapid discovery of antibodies targeting cell membrane proteins, including G-protein coupled receptors and ion channels.

CCC Combination Cell Library Technology

A technology platform for cell library construction and screening to support drug discovery and development.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - veloxpharma.com	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - veloxpharma.com	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - veloxpharma.com	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - veloxpharma.com	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - veloxpharma.com	2	obfuscated obfuscation	—	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - veloxpharma.com	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - veloxpharma.com	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - veloxpharma.com	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - veloxpharma.com	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - veloxpharma.com	2	obfuscated obfuscation	—	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Changzhou Properties	No	Series A - veloxpharma.com	—
Changzhou Properties	No	Series A - veloxpharma.com	—
Changzhou Properties	No	Series A - veloxpharma.com	—
Changzhou Properties	No	Series A - veloxpharma.com	—
Changzhou Properties	No	Series A - veloxpharma.com	—